New insights for the development of efficient DNA vaccines

Simone Berger,Yanira Zeyn,Ernst Wagner,Matthias Bros
DOI: https://doi.org/10.1111/1751-7915.70053
2024-11-23
Microbial Biotechnology
Abstract:The design of DNA vaccines and their mode of application need to be thoroughly improved to mount strong and sustained immune responses in humans, for example, by deleting prokaryotic sequences known to exert detrimental effects from the vector backbone, or by nanoformulated delivery that allows cell type‐specific transfection and codelivery of adjuvants. Despite the great potential of DNA vaccines for a broad range of applications, ranging from prevention of infections, over treatment of autoimmune and allergic diseases to cancer immunotherapies, the implementation of such therapies for clinical treatment is far behind the expectations up to now. The main reason is the poor immunogenicity of DNA vaccines in humans. Consequently, the improvement of the performance of DNA vaccines in vivo is required. This mini‐review provides an overview of the current state of DNA vaccines and the various strategies to enhance the immunogenic potential of DNA vaccines, including (i) the optimization of the DNA construct itself regarding size, nuclear transfer and transcriptional regulation; (ii) the use of appropriate adjuvants; and (iii) improved delivery, for example, by careful choice of the administration route, physical methods such as electroporation and nanomaterials that may allow cell type‐specific targeting. Moreover, combining nanoformulated DNA vaccines with other immunotherapies and prime‐boost strategies may help to enhance success of treatment.
biotechnology & applied microbiology,microbiology
What problem does this paper attempt to address?